Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Microport Neurotech Co., Ltd.

Clinical trials sponsored by Microport Neurotech Co., Ltd., explained in plain language.

Now part of MicroPort NeuroScientific Corporation 2172 HKEX

A medical device company focused on neurovascular interventions.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New liquid embolic agent could shrink dangerous brain malformations

Disease control Recruiting now

This study tests a new liquid embolic agent to treat brain arteriovenous malformations (AVMs), which are tangles of abnormal blood vessels that can cause bleeding or stroke. About 116 adults aged 18 to 80 with certain types of AVMs will receive the treatment and be followed for o…

Phase: NA • Sponsor: MicroPort NeuroTech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC